Legal Representation
Attorney
Abe J. Shanehsaz
USPTO Deadlines
Next Deadline
110 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
November 21, 2025
Extension Available
Until May 21, 2025
Application History
31 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 1, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 30, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Apr 30, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Apr 30, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 5, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 5, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 5, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 5, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 21, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 26, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 26, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 6, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 6, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 21, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 21, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Feb 21, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 21, 2024 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 21, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Feb 20, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 20, 2024 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 20, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 12, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 11, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 11, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 1, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 1, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 1, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 28, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 18, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jul 17, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 16, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
glycolic acid; aspartate; dimeric aspartate, namely, iminodissuccinate, and ethylenediamine-N,N'-disuccinate; polysuccinimide; polyaspartate; polyaspartate polymers; polyaspartate polymeric additives; polyaspartate for use in the manufacture of industrial, consumer, agricultural, and household products; polyaspartate polymers for use in the manufacture of industrial, consumer, agricultural, and household products; polyaspartate polymeric additives for use in the manufacture of industrial, consumer, agricultural, and household products; Chemical substances for industrial use, namely, propanedioic acid, ethyl malonate, mono-methyl malonate, mono-ethyl malonate, mono-propyl malonate, mono-butyl malonate, mono-tert-butyl malonate, di-alkyl malonate esters, namely, dimethyl malonate, diethyl malonate, dipropyl malonate, dibutyl malonate, Meldrum's acid, dialkyl malonate, e-caprolactam, d-valerolactam, dialkylated 1,3-dicarbonyl compounds, namely, diethyl 2,2-dimethylmalonate, diethyl 2,2-diethylmalonate, diethyl 2,2-dipropylmalonate, diethyl 2,2-dibutylmalonate, dimethyl 2,2-dimethylmalonate, dimethyl 2,2-diethylmalonate, dimethyl 2,2-dipropylmalonate, and dimethyl 2,2-dibutylmalonate, lactic acid, pyruvic acid, hydroxypropionic acid, formate, succinic acid, 1,3-propanediol, and 2,3-butanediol, 1,4-butanediol; chemicals, biochemicals, and reagents, namely, recombinant proteins, expression vectors, oligonucleotides, amino acids for laboratory use, reagents for recombinant protein expression purification; chemical preparations and substances for use in the manufacture of chemical substances for industrial use
Class 005
organic molecules for pharmaceutical use
Class 042
Scientific and industrial research in the field of biochemistry; scientific biochemical laboratory services concerning particular synthesis of recombinant polypeptides and proteins for production of chemical substances for industrial use, namely, propanedioic acid, ethyl malonate, mono-methyl malonate, mono-ethyl malonate, mono-ethyl malonate, mono-propyl malonate, mono-butyl malonate, mono-tert-butyl malonate, and the like, di-alkyl malonate esters, namely, dimethyl malonate, diethyl malonate, dipropyl malonate, dibutyl malonate, and the like, Meldrum's acid, dialkyl malonate, e-caprolactam, d-valerolactam, dialkylated 1,3-dicarbonyl compounds, namely, diethyl 2,2-dimethylmalonate, diethyl 2,2-diethylmalonate, diethyl 2,2-dipropylmalonate, diethyl 2,2-dibutylmalonate, dimethyl 2,2-dimethylmalonate, dimethyl 2,2-diethylmalonate, dimethyl 2,2-dipropylmalonate, and dimethyl 2,2-dibutylmalonate, lactic acid, pyruvic acid, hydroxypropionic acid, formate, succinic acid, 1,3-propanediol, and 2,3-butanediol, 1,4-butanediol
Additional Information
Design Mark
The mark consists of a geometric sun design comprised of individual triangular quadrilaterals followed by the stylized word LYGOS.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
001
005
042